“moderna-therapeutics” Archives

in
Entry Author Date Location
From Alnylam to Zayner: Xconomy’s Top Innovation Stories of 2018 12/27/18 National
Morphic Nets Another $80M For Integrin Drugs & First Human Tests 09/25/18 Boston
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
With BioNTech Deal, Pfizer Becomes Latest to Bet on mRNA Vaccines 08/16/18 New York
Going Against the Grain: Meet the Xconomy Contrarian Award Finalists 08/01/18 Boston
The 2018 Xconomy Awards Finalists Are… 06/28/18 Boston
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines 06/11/18 Boston
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
Moderna’s Billions: Will Building Big Before an IPO Pay Off? 05/09/18 Boston
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Boston VC Continues Surge in Q1; Here are the Top 10 Deals 04/11/18 Boston
Expectations Rise on Q1 Surge in Venture Funding; and Top 10 Deals 04/10/18 National
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
Moderna, Still Private, Scoops Up Yet Another $500M 02/01/18 Boston
Flagship Bags $618M, Its Largest Raise Ever, For a New Startup Crop 12/20/17 Boston
15 For ’18: Key Clinical Data to Watch For Next Year (Part 2) 12/06/17 National
After Humanitarian Honor, Flagship’s Afeyan States Case for Immigration 12/06/17 Boston
Xconomy Q&A: An Update with Arcturus Therapeutics CEO Joseph Payne 10/23/17 San Diego
Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact 10/18/17 Indiana
Bio Roundup: Nobel Pursuit, Fundraising Fruit, A Rhythmic IPO & More 10/06/17 National
Dealmaker, Thought Leader & More: The X of the Year Xconomy Award Finalists 09/15/17 Boston
Moderna Ends “Venture” Experiment, Dissolves Four Startups 09/14/17 Boston
Bio Roundup: GOP Drama, Immunotherapy Setbacks, Pharma Revamps 07/28/17 National
With $23M, Flagship-Backed Sigilon Protects Protein-Producing Cells 06/21/17 Boston
Bio Leaders Mourn Passing of Genzyme Exec, Orphan Drug Innovator Termeer 05/14/17 Boston
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
Drugmakers, Amazon Back Grail’s Big Cancer Trials With $900M 03/01/17 San Francisco
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins 02/03/17 National
Biotech Roundup: JPM Deals, Gender Diversity, PCSK9 Battle & More 01/13/17 National
VC Activity in Boston Dipped in 2016; Here Are the Top 10 Deals & Exits 01/11/17 Boston
Page 1 of 5 next page »